Sensei Biotherapeutics In... (SNSE)
NASDAQ: SNSE
· Real-Time Price · USD
8.68
1.18 (15.73%)
At close: Aug 15, 2025, 3:59 PM
8.80
1.38%
After-hours: Aug 15, 2025, 07:56 PM EDT
Sensei Biotherapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 12.56M | 9.88M | 9.99M | 19.13M | 11.89M | 10.96M | 13.01M | 11.34M | 10.23M | 8.11M | 17.8M | 11.45M | 9.9M | 8.72M | 7.16M | 9.53M | 15.6M | 169.42M |
Short-Term Investments | 16.07M | 24.45M | 31.34M | 27.87M | 40.4M | 47.13M | 52.75M | 60.67M | 68.61M | 87.4M | 89.32M | 105.11M | 113.81M | 127.5M | 140.46M | 147.13M | 146.9M | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 24K | 24K | 48K | 87K | 87K | 86K | 86K | 1.91M | 86K | 81K | 63K | 45K | 45K | 39K | 39K | 27K | n/a | 36K |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 944K | 440K | 120K | 1.1M | 142K | 269K | 325K | 318K | 252K | 454K | 344K | 336K | 293K | 199K | 374K | 301K | 472K | 60K |
Total Current Assets | 29.57M | 35.68M | 41.93M | 48.1M | 53.94M | 60.23M | 67.25M | 72.01M | 81.07M | 98.61M | 108.59M | 118.48M | 127.49M | 138.98M | 148.54M | 158.16M | 165.61M | 172.78M |
Property-Plant & Equipment | 2.19M | 2.57M | 3.38M | 5.07M | 5.77M | 6.38M | 7.04M | 7.74M | 8.43M | 9.24M | 9.72M | 10.28M | 10.5M | 11.02M | 4.64M | 3.06M | 2.11M | 1.66M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 2.21M | 2.59M | 3.43M | 5.16M | 5.86M | 6.46M | 7.12M | 9.64M | 8.51M | 9.32M | 9.79M | 10.32M | 10.54M | 11.06M | 4.68M | 3.09M | 2.11M | 1.69M |
Total Assets | 31.78M | 38.27M | 45.36M | 53.25M | 59.8M | 66.69M | 74.37M | 81.66M | 89.58M | 107.93M | 118.38M | 128.8M | 138.04M | 150.04M | 153.22M | 161.25M | 167.72M | 174.48M |
Account Payables | n/a | 361K | n/a | n/a | 1.65M | 2M | 1.69M | 2.73M | 2.33M | n/a | 4.47M | 4.66M | 2.42M | 5.1M | 2.46M | 3.49M | 2.83M | 1.97M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.73M | -2.33M | n/a | -4.47M | n/a | -2.42M | -5.1M | n/a | n/a | n/a | n/a |
Short-Term Debt | 1.96M | n/a | 2.32M | n/a | 2.46M | n/a | 2.44M | 2.41M | 2.31M | n/a | n/a | 2.07M | 1.99M | 1.95M | 680K | n/a | n/a | n/a |
Other Current Liabilities | 1.91M | 795K | 3.13M | 3.01M | -1.61M | n/a | -929K | -1.31M | -1.6M | 5.3M | n/a | -311K | -973K | -1.39M | 1.07M | 156K | 1.09M | 64K |
Total Current Liabilities | 3.87M | 5.23M | 5.45M | 5.44M | 4.95M | 4.99M | 5.64M | 6.23M | 5.36M | 7.58M | 9.07M | 8.49M | 5.43M | 7.61M | 4.89M | 5.26M | 3.92M | 2.48M |
Long-Term Debt | 596K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 567K | 567K |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | 67K | 68K | 67K | 67K | 72K | 34K | n/a | n/a | n/a | n/a | 149K | 777K | 109K | 182K |
Total Long-Term Liabilities | 596K | 1.06M | 1.53M | 2.03M | 2.66M | 3.23M | 3.84M | 4.43M | 5.02M | 5.5M | 5.9M | 6.33M | 6.69M | 7.12M | 1.82M | 777K | 676K | 749K |
Total Liabilities | 4.47M | 6.29M | 6.97M | 7.47M | 7.61M | 8.22M | 9.48M | 10.66M | 10.38M | 13.08M | 14.97M | 14.82M | 12.12M | 14.73M | 6.71M | 6.04M | 4.6M | 3.22M |
Total Debt | 2.56M | 3.21M | 3.85M | 4.47M | 5.05M | 5.64M | 6.21M | 6.77M | 7.26M | 7.75M | 8.03M | 8.4M | 8.68M | 9.07M | 2.35M | 777K | 567K | 567K |
Common Stock | n/a | 3K | 3K | 3K | 3K | 3K | 3K | 2K | 3K | 3K | 3K | 3K | 3K | 3K | 3K | 3K | 3K | 3K |
Retained Earnings | -273.85M | -268.92M | -262.05M | -254.28M | -247.03M | -239.89M | -231.9M | -224.48M | -217.36M | -207.97M | -197.79M | -185.56M | -172.15M | -161.61M | -149.21M | -139.84M | -130.16M | -120.38M |
Comprehensive Income | -11K | -6K | -13K | 14K | -93K | -137K | -209K | -402K | -549K | -823K | -1M | -1.21M | -1.21M | -899K | -333K | -69K | -101K | -174.48M |
Shareholders Equity | 27.31M | 31.99M | 38.39M | 45.78M | 52.19M | 58.47M | 64.89M | 71M | 79.2M | 94.85M | 103.41M | 113.99M | 125.92M | 135.31M | 146.51M | 155.21M | 163.13M | 171.25M |
Total Investments | n/a | 24.45M | 31.34M | 27.87M | 40.4M | 47.13M | 52.75M | 60.67M | 68.61M | 87.4M | 89.32M | 105.11M | 113.81M | 127.5M | 140.46M | 147.13M | 146.9M | n/a |